Cargando…
Oral [60]fullerene reduces neuroinflammation to alleviate Parkinson's disease via regulating gut microbiome
Neuroinflammation is considered to drive the pathogenic process of neuronal degeneration in Parkinson's disease (PD). However, effective anti-neuroinflammation therapeutics for PD still remain dissatisfactory. Here we explore a robust therapeutic strategy for PD using anti-neuroinflammatory ful...
Autores principales: | Li, Xue, Deng, Ruijun, Li, Jie, Li, Hui, Xu, Zhe, Zhang, Lei, Feng, Linyin, Shu, Chunying, Zhen, Mingming, Wang, Chunru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526674/ https://www.ncbi.nlm.nih.gov/pubmed/37771782 http://dx.doi.org/10.7150/thno.85711 |
Ejemplares similares
-
Amphiphilic Aminated Derivatives of [60]Fullerene as Potent Inhibitors of Tumor Growth and Metastasis
por: Huo, Jiawei, et al.
Publicado: (2022) -
Amino acid modified [70] fullerene derivatives with high radical scavenging activity as promising bodyguards for chemotherapy protection
por: Zhou, Yue, et al.
Publicado: (2018) -
Effects of C60 Fullerene on Thioacetamide-Induced Rat Liver Toxicity and Gut Microbiome Changes
por: Đurašević, Siniša, et al.
Publicado: (2021) -
Reactions of [60]fullerene with alkynes promoted by OH(−)
por: Chang, Wei-Wei, et al.
Publicado: (2022) -
Base-iodine-promoted metal-catalyst-free reactions of [60]fullerene with β-keto esters for the selective formation of [60]fullerene derivatives
por: Yang, Han-Lin, et al.
Publicado: (2020)